Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- B. Riley Securities
- HC Wainwright & Co.
1calculated from analyst ratings published within the last 6 months
Analyst Ratings for Spectrum Pharmaceuticals
What is the target price for Spectrum Pharmaceuticals (SPPI)?
The latest price target for Spectrum Pharmaceuticals (NASDAQ: SPPI) was reported by B. Riley Securities on November 16, 2022. The analyst firm set a price target for $1.00 expecting SPPI to rise to within 12 months (a possible 116.17% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Spectrum Pharmaceuticals (SPPI)?
The latest analyst rating for Spectrum Pharmaceuticals (NASDAQ: SPPI) was provided by B. Riley Securities, and Spectrum Pharmaceuticals downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Spectrum Pharmaceuticals (SPPI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Spectrum Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Spectrum Pharmaceuticals was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
Is the Analyst Rating Spectrum Pharmaceuticals (SPPI) correct?
While ratings are subjective and will change, the latest Spectrum Pharmaceuticals (SPPI) rating was a downgraded with a price target of $1.50 to $1.00. The current price Spectrum Pharmaceuticals (SPPI) is trading at is $0.46, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.